ScholarLens Back to search
2005•Heilongjiang Medical JournalRequires access

Study on Regulating and Safety of Blood Lipid with Varied Dosage of Fluvastatin for CHD

Lin Yuan-ye

Open publisher page 0 citations

Abstract

Objective To observe the affection and safety of varied dosage of fluvastatin for blood lipid of CHD. Methods 50 cases of CHD patient with hyperlipemia were divided into 2 group (control group treated with 40 mg/d and therapy group treated with 80 mg/d) for 8 weeks as a course. Results The TC, LDL-C and TG were decreased obviously in both groups and lower after 4, 8 weeks in therapy group than those in control group (P0.05). There was no significant difference in lab test and side effect. Conclusion In the certain range, the high dose of fluvastatin might have good effect than lower dose and without side effect.

About this research paper

What this paper is about

Objective To observe the affection and safety of varied dosage of fluvastatin for blood lipid of CHD. Methods 50 cases of CHD patient with hyperlipemia were divided into 2 group (control group treated with 40 mg/d and therapy group treated with 80 mg/d) for 8 weeks as a course. Results The TC, LDL-C and TG were decreased obviously in both groups and lower after 4, 8 weeks in therapy group than those in control group (P0.05). There was no significant difference in lab test and side effect. Conclusion In the certain range, the high dose of fluvastatin might have good effect than lower dose and without side effect.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the affection and safety of varied dosage of fluvastatin for blood lipid of CHD. Methods 50 cases of CHD patient with hyperlipemia were divided into 2 group (control group treated with 40 mg/d and therapy group treated with 80 mg/d) for 8 weeks as a course. Results The TC, LDL-C and TG were decreased obviously in both groups and lower after 4, 8 weeks in therapy group than those in control group (P0.05). There was no significant difference in lab test and side effect. Conclusion In the certain range, the high dose of fluvastatin might have good effect than lower dose and without side effect.

Key concepts: Fluvastatin, Medicine, Blood lipids, Significant difference, Side effect (computer science), Surgery, Internal medicine, Pharmacology

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Study on Regulating and Safety of Blood Lipid with Varied Dosage of Fluvastatin for CHD — Research Paper | ScholarLens